Xometry Inc (XMTR) PT Raised to $120 at Rosenblatt

Rosenblatt analyst Scott Devitt raised the price target on Xometry Inc (NASDAQ: XMTR) to $120.00 (from $110.00) while maintaining a Buy rating.

The analyst commented: "On Monday, we hosted James Miln, CFO and Shawn Milne, VP of IR at Xometry for a meeting with investors. Our discussion covered a range of topics including near-term trends, the recent management transition, AI positioning, and broader enterprise strategy. Xometry has demonstrated a clear validation of its marketplace model at scale, in our view, with AI further compounding the platform's competitive advantage. The ongoing partnership with Siemens is an important distribution unlock as Xometry embeds its offering within more enterprise workflows. We come away with increasing conviction in the longer-term durability of growth, and our forecasts in the outer years of our model are raised accordingly. Following these revisions, our PT rises to $120 from $110 previously."

You May Also Be Interested In

• BMO Capital Starts HCA Healthcare Inc (HCA) at Outperform
• Decoy Therapeutics corrects warrant exercisability in inducement deal
• CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained